LEP and metabolic dysfunction-associated steatotic liver disease: MASLD is associated with elevated leptin levels (Jiménez-Cortegana et al., 2021), and increased leptin can disrupt the acidic environment of the esophageal lumen, leading to the initiation and progression of esophageal mucosal damage (Pardak et al., 2021).